Dose-response Analysis in Hepatic Tumors Treated with 90Y-TARE According to a Personalized Dosimetric Workflow: Preliminary Results

Kennedy, A. Radioembolization of hepatic tumors. J. Gastrointest. Oncol., 2014, 5(3), 178-189.
[PMID: 24982766]

Mahnken, A.H. Current status of transarterial radioembolization. World J. Radiol., 2016, 8(5), 449-459.
[http://dx.doi.org/10.4329/wjr.v8.i5.449] [PMID: 27247711]

Weber, M.; Lam, M.; Chiesa, C.; Konijnenberg, M.; Cremonesi, M.; Flamen, P.; Gnesin, S.; Bodei, L.; Kracmerova, T.; Luster, M.; Garin, E.; Herrmann, K. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur. J. Nucl. Med. Mol. Imaging, 2022, 49(5), 1682-1699.
[http://dx.doi.org/10.1007/s00259-021-05600-z] [PMID: 35146577]

Dezarn, W.A.; Cessna, J.T.; DeWerd, L.A.; Feng, W.; Gates, V.L.; Halama, J.; Kennedy, A.S.; Nag, S.; Sarfaraz, M.; Sehgal, V.; Selwyn, R.; Stabin, M.G.; Thomadsen, B.R.; Williams, L.E.; Salem, R. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90 Y microsphere brachytherapy in the treatment of hepatic malignancies. Med. Phys., 2011, 38(8), 4824-4845.
[http://dx.doi.org/10.1118/1.3608909] [PMID: 21928655]

Saini, A.; Wallace, A.; Alzubaidi, S.; Knuttinen, M.G.; Naidu, S.; Sheth, R.; Albadawi, H.; Oklu, R. History and evolution of Yttrium-90 Radioembolization for hepatocellular carcinoma. J. Clin. Med., 2019, 8(1), 55.
[http://dx.doi.org/10.3390/jcm8010055] [PMID: 30621040]

Cross, W.G.; Soares, C.G.; Vynckier, S.; Weaver, K. Dosimetry of beta rays and low-energy photons for brachytherapy with sealed sources, ICRU Report 72. J. ICRU, 2003.

Padia, S.A. Y90 Clinical Data Update: Cholangiocarcinoma, neuroendocrine tumor, melanoma, and breast cancer metastatic disease. Tech. Vasc. Interv. Radiol., 2019, 22(2), 81-86.
[http://dx.doi.org/10.1053/j.tvir.2019.02.008] [PMID: 31079715]

Wasan, H.S.; Gibbs, P.; Sharma, N.K.; Taieb, J.; Heinemann, V.; Ricke, J.; Peeters, M.; Findlay, M.; Weaver, A.; Mills, J.; Wilson, C.; Adams, R.; Francis, A.; Moschandreas, J.; Virdee, P.S.; Dutton, P.; Love, S.; Gebski, V.; Gray, A.; van Hazel, G.; Sharma, R.A.; Adams, R.; Bateman, A.; Blesing, C.; Brown, E.; Chau, I.; Cummins, S.; Cunningham, D.; Falk, S.; Hadaki, M.; Hall, M.; Hickish, T.; Hornbuckle, J.; Lofts, F.; Lowndes, S.; Mayer, A.; Metcalfe, M.; Middleton, G.; Mills, J.; Montazeri, A.; Muirhead, R.; Polychronis, A.; Purcell, C.; Ross, P.; Sharma, R.A.; Sherwin, L.; Smith, D.; Soomal, R.; Swinson, D.; Walther, A.; Wasan, H.; Weaver, A.; Wilson, C.; Wilson, G.; Amin, P.; Angelelli, B.; Balosso, J.; Beny, A.; Bloomgarden, D.; Boucher, E.; Brown, M.; Bruch, H-R.; Bui, J.; Burge, M.; Cardaci, G.; Carlisle, J.; Chai, S.; Chen, Y-J.; Chevallier, P.; Chuong, M.; Clarke, S.; Coveler, A.; Craninx, M.; Delanoit, T.; Deleporte, A.; Eliadis, P.; Facchini, F.; Ferguson, T.; Ferrante, M.; Findlay, M.; Frenette, G.; Frick, J.; Ganju, V.; Garofalo, M.; Geboes, K.; Gehbauer, G.; George, B.; Geva, R.; Gibbs, P.; Gordon, M.; Gregory, K.; Gulec, S.; Hannigan, J.; van Hazel, G.; Heching, N.; Heinemann, V.; Helmberger, T.; Hendlisz, A.; Hendrickx, K.; Holtzman, M.; Isaacs, R.; Jackson, C.; James, P.; Kaiser, A.; Karapetis, C.; Kaubisch, A.; Ko, Y-D.; Kröning, H.; Lammert, F.; Liauw, W.; Limentani, S.; Louafi, S.; de Man, M.; Margolis, J.; Martin, R.; Martoni, A.; Marx, G.; Matos, M.; Monsaert, E.; Moons, V.; Nott, L.; Nusch, A.; O’Donnell, A.; Ozer, H.; Padia, S.; Pavlakis, N.; Peeters, M.; Perez, D.; Pluntke, S.; Polus, M.; Powell, A.; Pracht, M.; Price, T.; Ransom, D.; Rebischung, C.; Ricke, J.; Ridwelski, K.; Riera-Knorrenschild, J.; Riess, H.; Rilling, W.; Robinson, B.; Rodríguez, J.; Sanchez, F.; Sauerbruch, T.; Savin, M.; Scheidhauer, K.; Schneiderman, E.; Seeger, G.; Segelov, E.; Schmueli, E.S.; Shani, A.; Shannon, J.; Sharma, N.; Shibata, S.; Singhal, N.; Smith, D.; Smith, R.; Stemmer, S.; Stötzer, O.; Strickland, A.; Taieb, J.; Tatsch, K.; Terrebonne, E.; Tichler, T.; Vehling-Kaiser, U.; Vera-Garcia, R.; Vogl, T.; Walpole, E.; Wang, E.; Whiting, S.; Wolf, I.; Ades, S.; Aghmesheh, M.; Angelelli, B.; Auber, M.; Ayala, H.; Beny, A.; Bloomgarden, D.; Boland, P.; Bouche, E.; Bowers, C.; Bremer, C.; Bui, J.; Burge, M.; Carlisle, J.; Casado, A.R.; Chai, S.; Chuong, M.; Cooray, P.; Crain, M.; De Wit, M.; Dowling, K.; Durand, A.; Facchini, F.; Faivre, S.; Feeney, K.; Ferguson, T.; Ferru, A.; Findlay, M.; Fragoso, M.; Frenette, G.; Frick, J.; Ganju, V.; Geva, R.; Gibbs, P.; Granetto, C.; Hammel, P.; van Hazel, G.; Heching, N.; Hendlisz, A.; Hendrickx, K.; Holtzman, M.; Issacs, R.; Iyer, R.; Jackson, C.; Kaiser, A.; Kaubisch, A.; Kim, Y.H.; Kröning, H.; Liang, J.T.; Lim, L.; Limentani, S.; Liu, J.H.; Louafi, S.; de Man, M.; Masi, G.; Matos, M.; Monsaert, E.; Mosconi, S.; Nott, L.; Numico, G.; O’Donnell, A.; Peeters, M.; Polus, M.; Pracht, M.; Ratner, L.; Rebischung, C.; Sae-Won, H.; Sanchez, F.; Shani, A.; Sharma, N.; Singh, M.; Singhal, N.; Smith, D.; Stoltzfus, P.; Strickland, A.; Taieb, J.; Tan, I.; Terrebonne, E.; Tichler, T.; Trogu, A.; Underhill, C.; Vera-Garcia, R.; Walpole, E.; Wang, E.; Westcott, M. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): A combined analysis of three multicentre, randomised, phase 3 trials. Lancet Oncol., 2017, 18(9), 1159-1171.
[http://dx.doi.org/10.1016/S1470-2045(17)30457-6] [PMID: 28781171]

Wang, T.H.; Huang, P.I.; Hu, Y.W.; Lin, K.H.; Liu, C.S.; Lin, Y.Y.; Liu, C.A.; Tseng, H.S.; Liu, Y.M.; Lee, R.C. Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry. PLoS One, 2018, 13(1), e0190098.
[http://dx.doi.org/10.1371/journal.pone.0190098] [PMID: 29293557]

Cremonesi, M.; Chiesa, C.; Strigari, L.; Ferrari, M.; Botta, F.; Guerriero, F.; De Cicco, C.; Bonomo, G.; Orsi, F.; Bodei, L.; Di Dia, A.; Grana, C.M.; Orecchia, R. Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective. Front. Oncol., 2014, 4, 210.
[http://dx.doi.org/10.3389/fonc.2014.00210] [PMID: 25191640]

Hermann, A.L.; Dieudonné, A.; Ronot, M.; Sanchez, M.; Pereira, H.; Chatellier, G.; Garin, E.; Castera, L.; Lebtahi, R.; Vilgrain, V. Relationship of tumor radiation–absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90Y in the SARAH study. Radiology, 2020, 296(3), 673-684.
[http://dx.doi.org/10.1148/radiol.2020191606] [PMID: 32602828]

Levillain, H.; Duran Derijckere, I.; Ameye, L.; Guiot, T.; Braat, A.; Meyer, C.; Vanderlinden, B.; Reynaert, N.; Hendlisz, A.; Lam, M.; Deroose, C.M.; Ahmadzadehfar, H.; Flamen, P. Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: A multicenter study. Eur. J. Nucl. Med. Mol. Imaging, 2019, 46(11), 2270-2279.
[http://dx.doi.org/10.1007/s00259-019-04427-z] [PMID: 31324943]

Garin, E.; Tselikas, L.; Guiu, B.; Chalaye, J.; Edeline, J.; de Baere, T.; Assénat, E.; Tacher, V.; Robert, C.; Terroir-Cassou-Mounat, M.; Mariano-Goulart, D.; Amaddeo, G.; Palard, X.; Hollebecque, A.; Kafrouni, M.; Regnault, H.; Boudjema, K.; Grimaldi, S.; Fourcade, M.; Kobeiter, H.; Vibert, E.; Le Sourd, S.; Piron, L.; Sommacale, D.; Laffont, S.; Campillo-Gimenez, B.; Rolland, Y.; Garin, E.; Edeline, J.; Robert, C.R.; Le Sourd, S.; Palard, X.; Laffont, S.; Campillo-Gimenez, B.; Rolland, Y.; Pracht, M.; Ardisson, V.; Lenoir, L.; Boudjema, K.; Tselikas, L.; De Baere, T.; Terroir-Cassou-Mounat, M.; Hollebecque, A.; Grimaldi, S.; Deschamps, F.; Ducreux, M.; Gelli, M.; Vibert, E.; Guiu, B.; Piron, L.; Kafrouni, M.; Fourcade, M.; Assenat, E.; Mariano-Goulart, D.; Cassinotto, C.; Allimant, C.; Chalaye, J.; Regnault, H.; Amaddeo, G.; Sommacale, D.; Kobeiter, H.; Tacher, V.; Bonnot-Lours, S.; Marie, M.; Itti, E.; Lerman, L.; Abulizi, M.; Luciani, A.; Costentin, C.E.; Milliner, M. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): A randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol. Hepatol., 2021, 6(1), 17-29.
[http://dx.doi.org/10.1016/S2468-1253(20)30290-9] [PMID: 33166497]

Willowson, K.P.; Hayes, A.R.; Chan, D.L.H.; Tapner, M.; Bernard, E.J.; Maher, R.; Pavlakis, N.; Clarke, S.J.; Bailey, D.L. Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: A retrospective exploratory analysis. EJNMMI Res., 2017, 7(1), 46.
[http://dx.doi.org/10.1186/s13550-017-0292-1] [PMID: 28536968]

Roosen, J.; Klaassen, N.J.M.; Westlund Gotby, L.E.L.; Overduin, C.G.; Verheij, M.; Konijnenberg, M.W.; Nijsen, J.F.W. To 1000 Gy and back again: A systematic review on dose-response evaluation in selective internal radiation therapy for primary and secondary liver cancer. Eur. J. Nucl. Med. Mol. Imaging, 2021, 48(12), 3776-3790.
[http://dx.doi.org/10.1007/s00259-021-05340-0] [PMID: 33839892]

Dutton, S.J.; Kenealy, N.; Love, S.B.; Wasan, H.S.; Sharma, R.A. FOXFIRE protocol: An open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer. BMC Cancer, 2014, 14(1), 497.
[http://dx.doi.org/10.1186/1471-2407-14-497] [PMID: 25011439]

van Hazel, G.A.; Heinemann, V.; Sharma, N.K.; Findlay, M.P.N.; Ricke, J.; Peeters, M.; Perez, D.; Robinson, B.A.; Strickland, A.H.; Ferguson, T.; Rodríguez, J.; Kröning, H.; Wolf, I.; Ganju, V.; Walpole, E.; Boucher, E.; Tichler, T.; Shacham-Shmueli, E.; Powell, A.; Eliadis, P.; Isaacs, R.; Price, D.; Moeslein, F.; Taieb, J.; Bower, G.; Gebski, V.; Van Buskirk, M.; Cade, D.N.; Thurston, K.; Gibbs, P. SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. J. Clin. Oncol., 2016, 34(15), 1723-1731.
[http://dx.doi.org/10.1200/JCO.2015.66.1181] [PMID: 26903575]

Vilgrain, V.; Pereira, H.; Assenat, E.; Guiu, B.; Ilonca, A.D.; Pageaux, G.P.; Sibert, A.; Bouattour, M.; Lebtahi, R.; Allaham, W.; Barraud, H.; Laurent, V.; Mathias, E.; Bronowicki, J.P.; Tasu, J.P.; Perdrisot, R.; Silvain, C.; Gerolami, R.; Mundler, O.; Seitz, J.F.; Vidal, V.; Aubé, C.; Oberti, F.; Couturier, O.; Brenot-Rossi, I.; Raoul, J.L.; Sarran, A.; Costentin, C.; Itti, E.; Luciani, A.; Adam, R.; Lewin, M.; Samuel, D.; Ronot, M.; Dinut, A.; Castera, L.; Chatellier, G.; Assenat, E. Delhom - Christol, E.; Guiu, B.; Ilonca, A.D.; Lonjon, J.; Pageaux, G-P.; Abdel-Rehim, M.; Allaham, W.; Bouattour, M.; Castera, L.; Dieudonné, A.; Lebtahi, R.; Ronot, M.; Sibert, A.; Vilgrain, V.; Barraud, H.; Bazin, C.; Bronowicki, J-P.; Laurent, V.; Mathias, E.; Chagneau-Derrode, C.; Perdrisot, R.; Silvain, C.; Tasu, J-P.; Borentain, P.; Gerolami, R.; Mundler, O.; Seitz, J-F.; Vidal, V.; Aubé, C.; Bouvier, A.; Couturier, O.; Oberti, F.; Vervueren, L.; Brenot-Rossi, I.; Raoul, J-L.; Sarran, A.; Chalaye, J.; Costentin, C.; Itti, E.; Kobeiter, H.; Luciani, A.; Adam, R.; Lewin, M.; Samuel, D.; Edeline, J.; Garin, E.; Rolland, Y.; Archambeaud, I.; Eugene, T.; Frampas, E.; Cassinotto, C.; Guyot, M.; Hiriart, J-B.; Lapuyade, B.; Vergniol, J.; Bachellier, P.; Detour, J.; Duclos, B.; Greget, M.; Habersetzer, F.; Imperiale, A.; Merle, P.; Rode, A.; Morvan, J.; Nguyen-Khac, E.; Yzet, T.; Baudin, G.; Chevallier, P.; Mahamat, A.; Piche, T.; Razzouk, M.; Hillon, P.; Loffroy, R.; Toubeau, M.; Vincent, J.; Barabino, G.; Bouarioua, N.; Cuilleron, M.; Ecochard, M.; Prevot-Bitot, N.; Leroy, V.; Roux, J.; Sengel, C.; Bourcier, V.; Ganne-Carrie, N.; Seror, O.; Costo, S.; Dao, T.; Pelage, J-P.; Dumortier, J.; Giammarile, F.; Valette, P-J.; Ghazzar, N.; Pellerin, O.; Taieb, J.; Weinmann, P.; Heurgue-Berlot, A.; Marcus, C.; Sommacale, D.; Castilla-Lièvre, M-A.; Maitre, S.; Marthey, L. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): An open-label randomised controlled phase 3 trial. Lancet Oncol., 2017, 18(12), 1624-1636.
[http://dx.doi.org/10.1016/S1470-2045(17)30683-6] [PMID: 29107679]

Chen, E.J.; Safwan Selvam, H.S.; Tan, T.H.; Chew, M.T. Quantitative analysis of xQuant reconstruction algorithm in SPECT/CT. Radiat. Phys. Chem., 2021, 188, 109683.
[http://dx.doi.org/10.1016/j.radphyschem.2021.109683]

Bolch, W.E.; Bouchet, L.G.; Robertson, J.S.; Wessels, B.W.; Siegel, J.A.; Howell, R.W.; Erdi, A.K.; Aydogan, B.; Costes, S.; Watson, E.E.; Brill, A.B.; Charkes, N.D.; Fisher, D.R.; Hays, M.T.; Thomas, S.R. MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions-radionuclide S values at the voxel level. J. Nucl. Med., 1999, 40(1), 11S-36S.
[PMID: 9935083]

Capotosti, A.; Moretti, R.; Milano, A.; Nardini, M.; Cusumano, D.; Annunziata, S.; Capogni, M.; D’Arienzo, M.; Placidi, L.; Indovina, L. Up-to-Date optimization of the 90Y-PET/CT reconstruction protocol for volumetric quantification in Trans-Arterial RadioEmbolization (TARE) procedures in the era of theranostics. Appl. Sci., 2022, 12(17), 8418.
[http://dx.doi.org/10.3390/app12178418]

Llovet, J.M.; Lencioni, R. mRECIST for HCC: Performance and novel refinements. J. Hepatol., 2020, 72(2), 288-306.
[http://dx.doi.org/10.1016/j.jhep.2019.09.026] [PMID: 31954493]

Giannini, E.; Botta, F.; Testa, E.; Romagnoli, P.; Polegato, S.; Malfatti, F.; Fumagalli, A.; Chiarbonello, B.; Risso, D.; Testa, R. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis. Am. J. Gastroenterol., 2002, 97(11), 2855-2860.
[http://dx.doi.org/10.1111/j.1572-0241.2002.07053.x] [PMID: 12425560]

Dunfee, B.L.; Riaz, A.; Lewandowski, R.J.; Ibrahim, S.; Mulcahy, M.F.; Ryu, R.K.; Atassi, B.; Sato, K.T.; Newman, S.; Omary, R.A.; Benson, A., III; Salem, R. Yttrium-90 radioembolization for liver malignancies: Prognostic factors associated with survival. J. Vasc. Interv. Radiol., 2010, 21(1), 90-95.
[http://dx.doi.org/10.1016/j.jvir.2009.09.011] [PMID: 19939705]

Gui, B.; Weiner, A.A.; Nosher, J.; Lu, S.E.; Foltz, G.M.; Hasan, O.; Kim, S.K.; Gendel, V.; Mani, N.B.; Carpizo, D.R.; Saad, N.E.; Kennedy, T.J.; Zuckerman, D.A.; Olsen, J.R.; Parikh, P.J.; Jabbour, S.K. Assessment of the Albumin-Bilirubin (ALBI) grade as a prognostic indicator for hepatocellular carcinoma patients treated with radioembolization. Am. J. Clin. Oncol., 2018, 41(9), 861-866.
[http://dx.doi.org/10.1097/COC.0000000000000384] [PMID: 28418940]

Michl, M.; Haug, A.R.; Jakobs, T.F.; Paprottka, P.; Hoffmann, R.T.; Bartenstein, P.; Boeck, S.; Haas, M.; Laubender, R.P.; Heinemann, V. Radioembolization with Yttrium-90 microspheres (SIRT) in pancreatic cancer patients with liver metastases: Efficacy, safety and prognostic factors. Oncology, 2014, 86(1), 24-32.
[http://dx.doi.org/10.1159/000355821] [PMID: 24401529]

Sangro, B.; Gil-Alzugaray, B.; Rodriguez, J.; Sola, I.; Martinez-Cuesta, A.; Viudez, A.; Chopitea, A.; Iñarrairaegui, M.; Arbizu, J.; Bilbao, J.I. Liver disease induced by radioembolization of liver tumors. Cancer, 2008, 112(7), 1538-1546.
[http://dx.doi.org/10.1002/cncr.23339] [PMID: 18260156]

Kao, Y.H.; Steinberg, J.D.; Tay, Y.S.; Lim, G.K.Y.; Yan, J.; Townsend, D.W.; Budgeon, C.A.; Boucek, J.A.; Francis, R.J.; Cheo, T.S.T.; Burgmans, M.C.; Irani, F.G.; Lo, R.H.G.; Tay, K.H.; Tan, B.S.; Chow, P.K.H.; Satchithanantham, S.; Tan, A.E.H.; Ng, D.C.E.; Goh, A.S.W. Post-radioembolization yttrium-90 PET/CT-part 2: Dose-response and tumor predictive dosimetry for resin microspheres. EJNMMI Res., 2013, 3(1), 57.
[http://dx.doi.org/10.1186/2191-219X-3-57] [PMID: 23885971]

Chan, K.T.; Alessio, A.M.; Johnson, G.E.; Vaidya, S.; Kwan, S.W.; Monsky, W.; Wilson, A.E.; Lewis, D.H.; Padia, S.A. Prospective trial using internal pair-production positron emission tomography to establish the Yttrium-90 radioembolization dose required for response of hepatocellular carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 2018, 101(2), 358-365.
[http://dx.doi.org/10.1016/j.ijrobp.2018.01.116] [PMID: 29559288]

Romanò, C.; Mazzaglia, S.; Maccauro, M.; Spreafico, C.; Gabutti, A.; Maffi, G.; Morosi, C.; Cascella, T.; Mira, M.; De Nile, M.C.; Aliberti, G.; Argiroffi, G.; Fuoco, V.; Bhoori, S.; Zanette, C.; Marchianò, A.; Seregni, E.; Mazzaferro, V.; Chiesa, C. Radioembolization of hepatocellular carcinoma with 90Y glass microspheres: No advantage of voxel dosimetry with respect to mean dose in dose–response analysis with two radiological methods. Cancers, 2022, 14(4), 959.
[http://dx.doi.org/10.3390/cancers14040959] [PMID: 35205712]

Nodari, G.; Popoff, R.; Riedinger, J.M.; Lopez, O.; Pellegrinelli, J.; Dygai-Cochet, I.; Tabouret-Viaud, C.; Presles, B.; Chevallier, O.; Gehin, S.; Gallet, M.; Latournerie, M.; Manfredi, S.; Loffroy, R.; Vrigneaud, J.M.; Cochet, A. Impact of contouring methods on pre-treatment and post-treatment dosimetry for the prediction of tumor control and survival in HCC patients treated with selective internal radiation therapy. EJNMMI Res., 2021, 11(1), 24.
[http://dx.doi.org/10.1186/s13550-021-00766-x] [PMID: 33687596]

Annunziata, S.; Treglia, G.; Caldarella, C.; Galiandro, F. The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with Yttrium-90: A first evidence-based review. Sci. World J., 2014, 2014, 879469.

Smits, M.L.J.; Elschot, M.; Sze, D.Y.; Kao, Y.H.; Nijsen, J.F.W.; Iagaru, A.H.; de Jong, H.W.A.M.; van den Bosch, M.A.A.J.; Lam, M.G.E.H. Radioembolization dosimetry: The road ahead. Cardiovasc. Intervent. Radiol., 2015, 38(2), 261-269.
[http://dx.doi.org/10.1007/s00270-014-1042-7] [PMID: 25537310]

Schiller, E.; Bergmann, R.; Pietzsch, J.; Noll, B.; Sterger, A.; Johannsen, B.; Wunderlich, G.; Pietzsch, H.J. Yttrium-86-labelled human serum albumin microspheres: Relation of surface structure with in vivo stability. Nucl. Med. Biol., 2008, 35(2), 227-232.
[http://dx.doi.org/10.1016/j.nucmedbio.2007.10.008] [PMID: 18312833]